72 related articles for article (PubMed ID: 35298821)
1. In Silico Maturation of a Nanomolar Antibody against the Human CXCR2.
Buratto D; Wan Y; Shi X; Yang G; Zonta F
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139124
[TBL] [Abstract][Full Text] [Related]
2. Molecular biomimetics: GEPI-based biological routes to technology.
Tamerler C; Khatayevich D; Gungormus M; Kacar T; Oren EE; Hnilova M; Sarikaya M
Biopolymers; 2010; 94(1):78-94. PubMed ID: 20091881
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Computational Models for the Study of Protein-Peptide Interactions.
Kilburg D; Gallicchio E
Adv Protein Chem Struct Biol; 2016; 105():27-57. PubMed ID: 27567483
[TBL] [Abstract][Full Text] [Related]
4. Computational Evolution Protocol for Peptide Design.
Ochoa R; Soler MA; Gladich I; Battisti A; Minovski N; Rodriguez A; Fortuna S; Cossio P; Laio A
Methods Mol Biol; 2022; 2405():335-359. PubMed ID: 35298821
[TBL] [Abstract][Full Text] [Related]
5. Designing High-Affinity Peptides for Organic Molecules by Explicit Solvent Molecular Dynamics.
Gladich I; Rodriguez A; Hong Enriquez RP; Guida F; Berti F; Laio A
J Phys Chem B; 2015 Oct; 119(41):12963-9. PubMed ID: 26398715
[TBL] [Abstract][Full Text] [Related]
6. Protocol for iterative optimization of modified peptides bound to protein targets.
Ochoa R; Cossio P; Fox T
J Comput Aided Mol Des; 2022 Nov; 36(11):825-835. PubMed ID: 36258137
[TBL] [Abstract][Full Text] [Related]
7. Insights on peptide topology in the computational design of protein ligands: the example of lysozyme binding peptides.
Cantarutti C; Vargas MC; Dongmo Foumthuim CJ; Dumoulin M; La Manna S; Marasco D; Santambrogio C; Grandori R; Scoles G; Soler MA; Corazza A; Fortuna S
Phys Chem Chem Phys; 2021 Oct; 23(40):23158-23172. PubMed ID: 34617942
[TBL] [Abstract][Full Text] [Related]
8. A consensus protocol for the in silico optimisation of antibody fragments.
Soler MA; Medagli B; Semrau MS; Storici P; Bajc G; de Marco A; Laio A; Fortuna S
Chem Commun (Camb); 2019 Nov; 55(93):14043-14046. PubMed ID: 31690899
[TBL] [Abstract][Full Text] [Related]
9. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
Foffi G; Pastore A; Piazza F; Temussi PA
Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
[TBL] [Abstract][Full Text] [Related]
10. FASPR: an open-source tool for fast and accurate protein side-chain packing.
Huang X; Pearce R; Zhang Y
Bioinformatics; 2020 Jun; 36(12):3758-3765. PubMed ID: 32259206
[TBL] [Abstract][Full Text] [Related]
11. HER2-targeted therapies - a role beyond breast cancer.
Oh DY; Bang YJ
Nat Rev Clin Oncol; 2020 Jan; 17(1):33-48. PubMed ID: 31548601
[TBL] [Abstract][Full Text] [Related]
12. Predicting the Affinity of Peptides to Major Histocompatibility Complex Class II by Scoring Molecular Dynamics Simulations.
Ochoa R; Laio A; Cossio P
J Chem Inf Model; 2019 Aug; 59(8):3464-3473. PubMed ID: 31290667
[TBL] [Abstract][Full Text] [Related]
13. Phage Display to Detect and Identify Autoantibodies in Disease.
Deutscher S
N Engl J Med; 2019 Jul; 381(1):89-91. PubMed ID: 31269373
[No Abstract] [Full Text] [Related]
14. The future of peptides in cancer treatment.
Kurrikoff K; Aphkhazava D; Langel Ü
Curr Opin Pharmacol; 2019 Aug; 47():27-32. PubMed ID: 30856511
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
